The Self-management App 'MinUrinsyregikt' for Patients With Gout. The ReMonit Gout Feasibility Study in Primary Care
Sponsor: Diakonhjemmet Hospital
Trial Details
| Condition | Gout |
| Intervention | Patient self-management app 'MinUrinsyregikt' |
| Phase | NA |
| Status | Recruiting |
| Participants | 50 |
| Est. Completion | 1 Dec 2027 |
| Last Updated | 30 Apr 2026 |
Primary Outcome
Acceptable overall feasibility of the app based on a total evaluation of the secondary endpoints for technical and operational feasibility.; Acceptable overall trial feasibility based on the total evaluation of the secondary endpoints for trial feasibility.
Eligibility Criteria
Inclusion Criteria
Patients are eligible to be included in the study only if all the following criteria apply: * Adults ≥18 years of age at screening * Patients with a clinical diagnosis of gout * Serum urate level \>360 µmol/L at inclusion * Indication for urate lowering therapy assessed by medical doctor * Having a smartphone/tablet Patients are excluded from the study if any of the following criteria apply: * Pregnant or breastfeeding * Contraindication for urate lowering therapy * Does not understand Norwegian language * Major co-morbidities (e.g., malignancies, severe chronic kidney disease, severe mental disorders)
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service